Overview
Circadia Health offers AI-powered, contactless patient monitoring for senior care. A bedside radar device tracks respiratory rate, heart rate, motion, and bed exits from up to eight feet away, with its data analyzed by AI to predict health events hours or days in advance; virtual nurses review the signals and provide 24/7 predictive risk alerts, integrated into electronic health records. The system is FDA-cleared (C100 for respiratory rate in 2020 and C200 for heart rate, motion, and bed exit in 2024) and is offered on a subscription basis to skilled nursing facilities and other long-term care providers. Its goal is to move healthcare from reacting to problems toward predicting and preventing deterioration, reducing preventable hospitalizations and care costs while improving senior outcomes.
Work here?Claim your company
Simplify's take
What believers are saying
- FDA cleared CX00 on October 15, 2026, expanding heart rate use cases.
- Circadia funded September 29, 2026 Nature validation, strengthening clinical credibility.
- The company is still hiring aggressively in November 2026, suggesting deployment demand and cash access.
What critics are saying
- Remote monitoring reimbursement drives revenue; CMS rule changes in 2027 can crush unit economics.
- 65 open roles on November 8, 2026 signal heavy hiring before durable hospital-system adoption.
- If CX00 false alarms miss sepsis, buyers will churn and regulators will scrutinize claims.
What makes Circadia Health unique
- Circadia’s FDA-cleared CX00 and C300 monitor vitals contactlessly from eight feet away.
- Its virtual nurses combine device signals with EHR trends for 24/7 predictive alerts.
- Radar-based monitoring avoids wearables, bed sensors, and patient compliance problems in SNFs.
Help us improve and share your feedback! Did you find this helpful?